320 related articles for article (PubMed ID: 16125709)
21. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.
Niculescu LS; Vlădică M; Sima AV
Biochem Biophys Res Commun; 2010 Jan; 391(1):587-91. PubMed ID: 19932084
[TBL] [Abstract][Full Text] [Related]
22. The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?
van Dijk KW; Rensen PC; Voshol PJ; Havekes LM
Curr Opin Lipidol; 2004 Jun; 15(3):239-46. PubMed ID: 15166778
[TBL] [Abstract][Full Text] [Related]
23. Impact of apolipoprotein A5 (APOA5) polymorphisms on serum triglyceride levels in schizophrenic patients under long-term atypical antipsychotic treatment.
Hong CJ; Chen TT; Bai YM; Liou YJ; Tsai SJ
World J Biol Psychiatry; 2012 Jan; 13(1):22-9. PubMed ID: 21375366
[TBL] [Abstract][Full Text] [Related]
24. Genetic association study of APOA1/C3/A4/A5 gene cluster and haplotypes on triglyceride and HDL cholesterol in a community-based population.
Chien KL; Chen MF; Hsu HC; Su TC; Chang WT; Lee CM; Lee YT
Clin Chim Acta; 2008 Feb; 388(1-2):78-83. PubMed ID: 17964293
[TBL] [Abstract][Full Text] [Related]
25. Rs964184 (APOA5-A4-C3-A1) is related to elevated plasma triglyceride levels, but not to an increased risk for vascular events in patients with clinically manifest vascular disease.
van de Woestijne AP; van der Graaf Y; de Bakker PI; Asselbergs FW; Spiering W; Visseren FL;
PLoS One; 2014; 9(6):e101082. PubMed ID: 24979386
[TBL] [Abstract][Full Text] [Related]
26. Elevated levels of triglyceride and triglyceride-rich lipoprotein triglyceride induced by a high-carbohydrate diet is associated with polymorphisms of APOA5-1131T>C and APOC3-482C>T in Chinese healthy young adults.
Lin J; Fang DZ; Du J; Shigdar S; Xiao LY; Zhou XD; Duan W
Ann Nutr Metab; 2011; 58(2):150-7. PubMed ID: 21646779
[TBL] [Abstract][Full Text] [Related]
27. Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study.
Lai CQ; Demissie S; Cupples LA; Zhu Y; Adiconis X; Parnell LD; Corella D; Ordovas JM
J Lipid Res; 2004 Nov; 45(11):2096-105. PubMed ID: 15342688
[TBL] [Abstract][Full Text] [Related]
28. Relationship of the APOA5/A4/C3/A1 gene cluster and APOB gene polymorphisms with dyslipidemia.
Ou HJ; Huang G; Liu W; Ma XL; Wei Y; Zhou T; Pan ZM
Genet Mol Res; 2015 Aug; 14(3):9277-90. PubMed ID: 26345861
[TBL] [Abstract][Full Text] [Related]
29. The effect of APOA5 and APOC3 variants on lipid parameters in European Whites, Indian Asians and Afro-Caribbeans with type 2 diabetes.
Dorfmeister B; Cooper JA; Stephens JW; Ireland H; Hurel SJ; Humphries SE; Talmud PJ
Biochim Biophys Acta; 2007 Mar; 1772(3):355-63. PubMed ID: 17197160
[TBL] [Abstract][Full Text] [Related]
30. Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults.
Komurcu-Bayrak E; Onat A; Poda M; Humphries SE; Palmen J; Guclu F; Can G; Erginel-Unaltuna N
Clin Chem Lab Med; 2008; 46(6):778-84. PubMed ID: 18601598
[TBL] [Abstract][Full Text] [Related]
31. Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildren.
Endo K; Yanagi H; Araki J; Hirano C; Yamakawa-Kobayashi K; Tomura S
Hum Genet; 2002 Dec; 111(6):570-2. PubMed ID: 12436249
[TBL] [Abstract][Full Text] [Related]
32. Relationship between the distribution of plasma HDL subclasses and the polymorphisms of APOA5 in hypertriglyceridemia.
Long S; Chen Z; Han Y; Christopher DM; Zhang C; Yang Y; Tian Y
Clin Biochem; 2013 Jun; 46(9):733-9. PubMed ID: 23499587
[TBL] [Abstract][Full Text] [Related]
33. APOA5-1131T>C genotype effects on apolipoprotein A5 and triglyceride levels in response to dietary intervention and regular exercise (DIRE) in hypertriglyceridemic subjects.
Jang Y; Chae JS; Kim OY; Park HJ; Kim JY; Paik JK; Lee SH; Lee JH
Atherosclerosis; 2010 Aug; 211(2):512-9. PubMed ID: 20392444
[TBL] [Abstract][Full Text] [Related]
34. A functional variant in APOA5/A4/C3/A1 gene cluster contributes to elevated triglycerides and severity of CAD by interfering with microRNA 3201 binding efficiency.
Cui G; Li Z; Li R; Huang J; Wang H; Zhang L; Ding H; Wang DW
J Am Coll Cardiol; 2014 Jul; 64(3):267-77. PubMed ID: 25034063
[TBL] [Abstract][Full Text] [Related]
35. Association of APOA5 c.553G>T polymorphism with type 2 diabetes mellitus in a Chinese population.
Zhai G; Wen P; Guo L; Chen L
Clin Chem Lab Med; 2006; 44(11):1313-6. PubMed ID: 17087641
[TBL] [Abstract][Full Text] [Related]
36. Rare APOA5 mutations--clinical consequences, metabolic and functional effects: an ENID review.
Talmud PJ
Atherosclerosis; 2007 Oct; 194(2):287-92. PubMed ID: 17222847
[TBL] [Abstract][Full Text] [Related]
37. The functional interaction on in vitro gene expression of APOA5 SNPs, defining haplotype APOA52, and their paradoxical association with plasma triglyceride but not plasma apoAV levels.
Palmen J; Smith AJ; Dorfmeister B; Putt W; Humphries SE; Talmud PJ
Biochim Biophys Acta; 2008; 1782(7-8):447-52. PubMed ID: 18395529
[TBL] [Abstract][Full Text] [Related]
38. Analysis of apolipoprotein A5, c3, and plasma triglyceride concentrations in genetically engineered mice.
Baroukh N; Bauge E; Akiyama J; Chang J; Afzal V; Fruchart JC; Rubin EM; Fruchart-Najib J; Pennacchio LA
Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1297-302. PubMed ID: 15117734
[TBL] [Abstract][Full Text] [Related]
39. Determination of the functionality of common APOA5 polymorphisms.
Talmud PJ; Palmen J; Putt W; Lins L; Humphries SE
J Biol Chem; 2005 Aug; 280(31):28215-20. PubMed ID: 15941721
[TBL] [Abstract][Full Text] [Related]
40. Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese.
Liu ZK; Hu M; Baum L; Thomas GN; Tomlinson B
Atherosclerosis; 2010 Feb; 208(2):427-32. PubMed ID: 19732897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
